Cystatin C: New Clinical Chemistry Parameter Available For DRG:HYBRiD-XL

Sep 24, 2014Products

DRG is glad to announce the next release of a clinical chemistry assay. Cystatin C is the latest released parameter for DRG:HYBRiD-XL and is ready to be purchased!

Cystatin C: New clinical chemistry parameter available for DRG:HYBRiD-XL

DRG is glad to announce the next release of a clinical chemistry assay. Cystatin C is the latest released parameter forDRG:HYBRiD-XL and is ready to be purchased!

The assay includes 80 tests and has an incubation time of 10 min in total.

You may order with the following catalog number:

Cystatin C HYC-5320

[starbox]

News and Updates

BioCheck Inc Acquires DRG International Inc

by Oleg Vishnevski | Aug 18, 2021 | News | 0 Comments

Transformative deal significantly increases IVD development, manufacturing and sales channel for novel ELISA and Chemiluminescent immunoassay platforms.

Parasites & Helicobacter Pylori in Egyptian Children | Calprotectin- DRG:HYBRiD-XL

by Oleg Vishnevski | Apr 8, 2021 | News, Products | 0 Comments

Parasites & Helicobacter Pylori in Egyptian Children with or without Diabetes with Gastrointestinal Manifestations & High Calprotectin Level

Cortisol & Adrenal Androgens as Independent Predictors

by Oleg Vishnevski | Jan 28, 2021 | Products | 0 Comments

Cortisol and adrenal androgens as independent predictors of mortality in septic patients. Abstract Background and Objective To determine the prognostic value of cortisol, Dehydroepiandrosterone (DHEA) and Dehydroepiandrosterone-sulfate (DHEAS), together with their...

Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.